Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.235NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.65NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.165NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
V.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.149NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.413NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.9.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.107NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.469NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.80 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43.8 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.128 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.220NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.58NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.438NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.1.257NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.5.6 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.440NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.23.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.104 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.198NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAFNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BC.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-982.809US
AY.39.1.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.15 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.221.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used